4D Molecular Therapeutics, Inc.

FDMT · XNAS

CIK 1650648fmd_151DQ1H3H48J0G1W1FBE17DBKAManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2019 to Sep 30, 2026, 28 periods

Ratios computed from the standardized statements. Select a value to open its proof.